1. Catalog
  2. Nodes
  3. a(HBP:"Phenylthiazolyl-hydrazide")

a(HBP:"Phenylthiazolyl-hydrazide")

Equivalencies: 0 | Classes: 0 | Children: 0 | Explore

Entity

Name
Phenylthiazolyl-hydrazide
Namespace
HBP
Namespace Version
20190207
Namespace URL
https://raw.githubusercontent.com/pharmacome/terminology/cf4d8bb88754f036b943b4d94ad96e103dcb7149/export/hbp-names.belns

Appears in Networks 2

Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies v1.0.0

Caenorhabditis elegans models of tauopathy v1.0.0

In-Edges 1

bp(GO:locomotion) positiveCorrelation a(HBP:"Phenylthiazolyl-hydrazide") View Subject | View Object

For example, Fatouros et al. (68) tested several tau-aggregation inhibitor compounds such as methylene blue, a rhodanine derivative (bb14), and a phenylthiazolyl hydrazide derivative (BSc3094), which reduce the insoluble tau and partially suppress the Unc phenotype. PubMed:29191965

Appears in Networks:

Out-Edges 3

a(HBP:"Phenylthiazolyl-hydrazide") decreases a(HBP:"Tau aggregates") View Subject | View Object

These efforts have produced early-stage molecules of multiple different chemical classes, including rhodanine-based inhibitors, phenylthiazolylhydrazides, N-phenylamines, anthraquinones, benzothiazoles, phenothiazines and polyphenols [41] PubMed:21882945

Appears in Networks:

a(HBP:"Phenylthiazolyl-hydrazide") decreases a(HBP:"Tau aggregates") View Subject | View Object

For example, Fatouros et al. (68) tested several tau-aggregation inhibitor compounds such as methylene blue, a rhodanine derivative (bb14), and a phenylthiazolyl hydrazide derivative (BSc3094), which reduce the insoluble tau and partially suppress the Unc phenotype. PubMed:29191965

Appears in Networks:

a(HBP:"Phenylthiazolyl-hydrazide") positiveCorrelation bp(GO:locomotion) View Subject | View Object

For example, Fatouros et al. (68) tested several tau-aggregation inhibitor compounds such as methylene blue, a rhodanine derivative (bb14), and a phenylthiazolyl hydrazide derivative (BSc3094), which reduce the insoluble tau and partially suppress the Unc phenotype. PubMed:29191965

Appears in Networks:

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.